AmerisourceBergen Corporation (NYSE:ABC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) Peyton R. Howell and AmerisourceBergen Corporation (the “Company”) have agreed that she shall cease to be Executive Vice President and President, Health Systems & Specialty Care Solutions for the Company, effective as of the close of business on April 6, 2018. Ms. Howell is expected to remain as a non-executive employee of the Company through May 1, 2018. In connection with her departure, Ms. Howell will be entitled to receive compensation and benefits consistent with her Employment Agreement, which was filed as an exhibit to the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2011.
About AmerisourceBergen Corporation (NYSE:ABC)
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment’s operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.
